Dishman Pharmaceuticals and Chemicals today said its consolidated net profit declined by 44.5% to Rs 15 crore for the quarter ended June 30, 2011.
The company had recorded a net profit of Rs 27.2 crore for the same period in the previous financial year, Dishman Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
Total income of the company rose to Rs 243 crore for the quarter ended June 30, 2011, from Rs 212 crore in the same period last fiscal.
Shares of Dishman Pharmaceuticals were being quoted at Rs 89 per share in late afternoon trade on the BSE, down 2% from their previous close.
